Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019
The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015
High eosinophil counts predict decline in FEV1 : results from the CanCOLD study Source: Eur Respir J, 57 (5) 2000838; 10.1183/13993003.00838-2020 Year: 2021
Absolute neutrophil count in peripheral blood predict prognosis in lung cancer patients treated with anlotinib Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA) Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020
Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Peripheral blood eosinophil counts and serum total IgE on broncholdilator responsiveness in patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003
The relation between blood leucocyte count, erythrocyte sedimentation rate, high sensitive C-reactive protein and pulmonary parenchymal infiltration in young male patients with Chlamydia pneumoniae pneumonia Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020
Elevated C-reactive protein is associated with reduced lung function and exercise capacity in normal subjects. Are we born inflammed? Source: Eur Respir J 2006; 28: Suppl. 50, 331s Year: 2006
Clinical significance of blood neutrophil differential count in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
The relation of hemoglobin, hematocrit, leucocyte and platelet levels to the severity of lesion in patients with pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 310s Year: 2001
Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019
Systemic inflammation, blood eosinophils count and lung function in COPD patients Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017
Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017
Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017
Lack of seasonal variability of blood eosinophil counts in COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019
Blood eosinophils and lung function decline in young adults. Source: International Congress 2017 – Asthma and ACOS: predictors and clinical characteristics Year: 2017
Reproducibility of COPD blood eosinophil counts Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018